- ICH GCP
- Registro de ensayos clínicos de EE. UU.
- Ensayo clínico NCT07818551
Assessment of Pain Perception and the Impact of Central Sensitization on Biopsychosocial Manifestations During Physical Activity in Patients With Chronic Low Back Pain (BASICS)
The goal of this prospective observational study is to evaluate changes in cognitive and behavioural markers associated with central sensitisation between the start and end of an exercise retraining programme on an exercise bike, in adult patients suffering from chronic lower back pain associated with an untreated degenerative spine, worth or without referred pain.
The main changes it will evaluate are:
- Changes in cognitive and behavioural markers associated with central sensitisation between Day 0 and Day 40 during exercise retraining on an exercise bike as part of a rehabilitation programme for chronic low back pain
Participants will undergo the followings:
- A calibration test used to define moderate exertion on an ergocycle, corresponding to a perceived exertion of 4-5/10 on the modified Borg scale
- Exercise-induced pain intensity assessment tests to detect changes in the intensity of pain during physical activity and the activity's potential to cause pain, realised on ergocyle
- Exercise rehabilitation on an ergocycle
- Final tests to assess cognitive and behavioural markers related to central sensitisation and pain intensity, as at baseline.
Descripción general del estudio
Estado
Condiciones
Intervención / Tratamiento
Descripción detallada
Patients with chronic low back pain who are scheduled to receive care at the Musculoskeletal Rehabilitation Unit of the Cornouaille Rehabilitation Center in Concarneau for low back pain rehabilitation-either through a group program on a part-time inpatient basis or an individual program on a full-time inpatient basis-will be considered for inclusion in the study.
Eligible patients will be enrolled after the investigator has provided them with comprehensive verbal and written information, conducted initial assessments, verified the inclusion and exclusion criteria, and obtained signed informed consent from the patients. For inpatients, verification of inclusion and exclusion criteria will take place on the day of admission to the Concarneau PRC during the initial evaluation.
Upon admission, the patient is assessed according to standard criteria for the management of patients with low back pain (measurements of spinal mobility: Fingers-to-Floor Distance (FFD), spinal inclinometry in flexion and extension, lateral bending, Schober's test, muscle strength assessment: Shirado and Sorensen tests, measurement of hamstring and quadriceps hyperextensibility), to which are added the Oswestry Questionnaire to assess disability related to low back pain, the CSI questionnaire, which assesses symptoms of central sensitization, and an evaluation of various cognitive-behavioral markers related to central sensitization, including sensitization due to motor disorders (Luomajoki tests), sensitization due to kinesiophobia (Tempa Scale of Kinesiophobia and KINAP), and sensitization due to catastrophizing (Pain Catastrophizing Scale).
After enrollment, patients will undergo a calibration test on an exercise bike on Day 1 to determine the power required to maintain a constant moderate effort corresponding to an intensity of 4-5/10 on the modified Borg scale. Then, to assess the pain-inducing potential of exercise on an ergocycle, they will perform two tests (on Day 3 and Day 5) to evaluate changes in pain during moderate, sustained exercise.
During their rehabilitation for low back pain, patients undergo exercise retraining on an ergocycle. From Day 8 through Day 40 (3 times per week, on Mondays, Wednesdays, and Fridays), the patients' perceived exertion will be assessed at the end of each ergometer session to verify that they are indeed maintaining a constant moderate level of exertion.
Patients will be assessed on Day 40 to collect measurements of cognitive-behavioral markers related to central sensitization and pain intensity, as was done at enrollment.
Tipo de estudio
Inscripción (Estimado)
Fase
- No aplica
Contactos y Ubicaciones
Estudio Contacto
- Nombre: François GICQUEL
- Número de teléfono: +33290778080
- Correo electrónico: gicquelfrancois@hotmail.fr
Copia de seguridad de contactos de estudio
- Nombre: Mathilde Guillo
- Correo electrónico: mathilde.guillo@chu-brest.fr
Ubicaciones de estudio
-
-
-
Concarneau, Francia, 29900
- SMR pôle Réadaptation de Cornouaille
-
Contacto:
- François GICQUEL
- Número de teléfono: +33290778080
- Correo electrónico: francois.giquel@ugecam.assurance-maladie.fr
-
-
Criterios de participación
Criterio de elegibilidad
Edades elegibles para estudiar
- Adulto
- Adulto Mayor
Acepta Voluntarios Saludables
Descripción
Inclusion Criteria:
- Adult patients, ages 18 through 75 inclusive, admitted to the Musculoskeletal Rehabilitation Unit at the Concarneau Regional Hospital
- Chronic low back pain due to degenerative spine disease that has not been treated surgically, with or without referred pain
- Low back pain intensity of 4/10 or less on the EVA scale
- Pain lasting more than 12 months (= critical period for cerebral impairment)
- Oswestry score between 21% and 40%
- CSI score of 33/100 or higher for women and 25/100 or higher for men
- Patients enrolled in or covered by a social security program
- Patients who have signed a consent form
Exclusion Criteria:
- Patients with acute low back pain of traumatic or neoplastic origin
- Patients with a contraindication to moderate-intensity physical activity (Borg 4-5/10 on the modified Borg scale)
- Inability to participate in sessions due to pain unrelated to low back pain or a disability
- Pregnant or breastfeeding patients
- Patients under legal guardianship or conservatorship
Plan de estudios
¿Cómo está diseñado el estudio?
Detalles de diseño
- Propósito principal: Otro
- Asignación: N / A
- Modelo Intervencionista: Asignación de un solo grupo
- Enmascaramiento: Ninguno (etiqueta abierta)
Armas e Intervenciones
Grupo de participantes/brazo |
Intervención / Tratamiento |
|---|---|
|
Otro: Exercise rehabilitation on an ergocycle
|
Following enrolment, patients will undergo a calibration test on an ergocycle on Day 1 to determine the power required to maintain a constant moderate effort corresponding to an intensity of 4-5/10 on the modified Borg scale. Then, to assess the pain-inducing potential of exercise on the ergocycle, they will undertake two tests (on Day 3 and Day 5) to evaluate changes in pain during constant moderate exertion. During their rehabilitation programme for low back pain, patients will undergo exercise retraining on the ergocycle. From Day 8 to Day 40 (three times a week, on Mondays, Wednesdays and Fridays), the patients' perception of exertion will be assessed at the end of each exercise bike session to ensure that they are maintaining a constant moderate level of exertion. Patients will be assessed on Day 40 to collect data on cognitive and behavioural markers related to central sensitisation and pain intensity, as at baseline. |
¿Qué mide el estudio?
Medidas de resultado primarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Change in Luomajoki tests score
Periodo de tiempo: Baseline and Day 40
|
The Luomajoki test consists of six movement control tests assessing lumbar movement control.
The score is calculated as the number of positive tests and ranges from 0 to 6. Higher score is worse outcome.
|
Baseline and Day 40
|
|
Change in Tampa Scale of Kinesiophobia
Periodo de tiempo: Baseline and Day 40
|
The Tampa Scale of Kinesiophobia is a questionnaire used to assess kinesiophobia, defined as the fear of movement.
It consists of 17 items, each rated on a 4-point scale ranging from 1 ("strongly disagree") to 4 ("strongly agree").
The score is calculated as the sum of the 17 items and ranges from 17 to 68.
Higher score is worse outcome.
|
Baseline and Day 40
|
|
Change in KINAP score
Periodo de tiempo: Baseline and Day 40
|
The KINAP consists of presenting participants with photographs illustrating physical and sports activities.
For each photograph, participants are asked to rate, on a scale from 0% to 100%, the intensity of their fear regarding potential negative consequences (e.g., pain).
The total score is calculated as the mean of the ratings provided for all photographs and ranges from 0% to 100%.
Higher scores indicate greater fear and represent a worse outcome.
|
Baseline and Day 40
|
|
Change in Pain catastrophizing scale
Periodo de tiempo: Baseline and Day 40
|
The Pain Catastrophizing Scale is used to assess the tendency to exaggerate the threat of pain, ruminate about pain, and experience feelings of helplessness in relation to pain.
It consists of 13 items, each rated from 0 ("not at all") to 4 ("all the time").
The total score is calculated as the sum of the scores of the 13 items and ranges from 0 to 52 Higher score is worse outcome.
|
Baseline and Day 40
|
Medidas de resultado secundarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Pain score
Periodo de tiempo: Day 3, before cycle ergometer test initiation
|
Pain score will be measured using visual analogic scale.
Score goes from 0 cm to 10 cm.
Higher score is worse outcome.
|
Day 3, before cycle ergometer test initiation
|
|
Pain score
Periodo de tiempo: Day 3, 3 minutes after cycle ergometer test initiation, if applicable
|
Pain score will be measured using visual analogic scale.
Score goes from 0 cm to 10 cm.
Higher score is worse outcome.
|
Day 3, 3 minutes after cycle ergometer test initiation, if applicable
|
|
Pain score
Periodo de tiempo: Day 3, 6 minutes after cycle ergometer test initiation, if applicable
|
Pain score will be measured using visual analogic scale.
Score goes from 0 cm to 10 cm.
Higher score is worse outcome.
|
Day 3, 6 minutes after cycle ergometer test initiation, if applicable
|
|
Pain score
Periodo de tiempo: Day 3, 9 minutes after cycle ergometer test initiation, if applicable
|
Pain score will be measured using visual analogic scale.
Score goes from 0 cm to 10 cm.
Higher score is worse outcome.
|
Day 3, 9 minutes after cycle ergometer test initiation, if applicable
|
|
Pain score
Periodo de tiempo: Day 3, 12 minutes after cycle ergometer test initiation, if applicable
|
Pain score will be measured using visual analogic scale.
Score goes from 0 cm to 10 cm.
Higher score is worse outcome.
|
Day 3, 12 minutes after cycle ergometer test initiation, if applicable
|
|
Pain score
Periodo de tiempo: Day 3, 15 minutes after cycle ergometer test initiation, if applicable
|
Pain score will be measured using visual analogic scale.
Score goes from 0 cm to 10 cm.
Higher score is worse outcome.
|
Day 3, 15 minutes after cycle ergometer test initiation, if applicable
|
|
Pain score
Periodo de tiempo: Day 3, 18 minutes after cycle ergometer test initiation, if applicable
|
Pain score will be measured using visual analogic scale.
Score goes from 0 cm to 10 cm.
Higher score is worse outcome.
|
Day 3, 18 minutes after cycle ergometer test initiation, if applicable
|
|
Pain score
Periodo de tiempo: Day 3, 21 minutes after cycle ergometer test initiation, if applicable
|
Pain score will be measured using visual analogic scale.
Score goes from 0 cm to 10 cm.
Higher score is worse outcome.
|
Day 3, 21 minutes after cycle ergometer test initiation, if applicable
|
|
Pain score
Periodo de tiempo: Day 3, 24 minutes after cycle ergometer test initiation, if applicable
|
Pain score will be measured using visual analogic scale.
Score goes from 0 cm to 10 cm.
Higher score is worse outcome.
|
Day 3, 24 minutes after cycle ergometer test initiation, if applicable
|
|
Pain score
Periodo de tiempo: Day 3, 27 minutes after cycle ergometer test initiation, if applicable
|
Pain score will be measured using visual analogic scale.
Score goes from 0 cm to 10 cm.
Higher score is worse outcome.
|
Day 3, 27 minutes after cycle ergometer test initiation, if applicable
|
|
Pain score
Periodo de tiempo: Day 3, 30 minutes after cycle ergometer test initiation, if applicable
|
Pain score will be measured using visual analogic scale.
Score goes from 0 cm to 10 cm.
Higher score is worse outcome.
|
Day 3, 30 minutes after cycle ergometer test initiation, if applicable
|
|
Pain score
Periodo de tiempo: Day 5, before cycle ergometer test initiation
|
Pain score will be measured using visual analogic scale.
Score goes from 0 cm to 10 cm.
Higher score is worse outcome.
|
Day 5, before cycle ergometer test initiation
|
|
Pain score
Periodo de tiempo: Day 5, 3 minutes after cycle ergometer test initiation, if applicable
|
Pain score will be measured using visual analogic scale.
Score goes from 0 cm to 10 cm.
Higher score is worse outcome.
|
Day 5, 3 minutes after cycle ergometer test initiation, if applicable
|
|
Pain score
Periodo de tiempo: Day 5, 6 minutes after cycle ergometer test initiation, if applicable
|
Pain score will be measured using visual analogic scale.
Score goes from 0 cm to 10 cm.
Higher score is worse outcome.
|
Day 5, 6 minutes after cycle ergometer test initiation, if applicable
|
|
Pain score
Periodo de tiempo: Day 5, 9 minutes after cycle ergometer test initiation, if applicable
|
Pain score will be measured using visual analogic scale.
Score goes from 0 cm to 10 cm.
Higher score is worse outcome.
|
Day 5, 9 minutes after cycle ergometer test initiation, if applicable
|
|
Pain score
Periodo de tiempo: Day 5, 12 minutes after cycle ergometer test initiation, if applicable
|
Pain score will be measured using visual analogic scale.
Score goes from 0 cm to 10 cm.
Higher score is worse outcome.
|
Day 5, 12 minutes after cycle ergometer test initiation, if applicable
|
|
Pain score
Periodo de tiempo: Day 5, 15 minutes after cycle ergometer test initiation, if applicable
|
Pain score will be measured using visual analogic scale.
Score goes from 0 cm to 10 cm.
Higher score is worse outcome.
|
Day 5, 15 minutes after cycle ergometer test initiation, if applicable
|
|
Pain score
Periodo de tiempo: Day 5, 21 minutes after cycle ergometer test initiation, if applicable
|
Pain score will be measured using visual analogic scale.
Score goes from 0 cm to 10 cm.
Higher score is worse outcome.
|
Day 5, 21 minutes after cycle ergometer test initiation, if applicable
|
|
Pain score
Periodo de tiempo: Day 5, 24 minutes after cycle ergometer test initiation, if applicable
|
Pain score will be measured using visual analogic scale.
Score goes from 0 cm to 10 cm.
Higher score is worse outcome.
|
Day 5, 24 minutes after cycle ergometer test initiation, if applicable
|
|
Pain score
Periodo de tiempo: Day 5, 27 minutes after cycle ergometer test initiation, if applicable
|
Pain score will be measured using visual analogic scale.
Score goes from 0 cm to 10 cm.
Higher score is worse outcome.
|
Day 5, 27 minutes after cycle ergometer test initiation, if applicable
|
|
Pain score
Periodo de tiempo: Day 5, 30 minutes after cycle ergometer test initiation, if applicable
|
Pain score will be measured using visual analogic scale.
Score goes from 0 cm to 10 cm.
Higher score is worse outcome.
|
Day 5, 30 minutes after cycle ergometer test initiation, if applicable
|
|
Pain score
Periodo de tiempo: Baseline
|
Pain score will be measured using visual analogic scale.
Score goes from 0 cm to 10 cm.
Higher score is worse outcome.
|
Baseline
|
|
Luomajoki tests score
Periodo de tiempo: Baseline
|
The Luomajoki test consists of six movement control tests assessing lumbar movement control.
The score is calculated as the number of positive tests and ranges from 0 to 6. Higher score is worse outcome.
|
Baseline
|
|
Tampa Scale of Kinesiophobia
Periodo de tiempo: Baseline
|
The Tampa Scale of Kinesiophobia is a questionnaire used to assess kinesiophobia, defined as the fear of movement.
It consists of 17 items, each rated on a 4-point scale ranging from 1 ("strongly disagree") to 4 ("strongly agree").
The score is calculated as the sum of the 17 items and ranges from 17 to 68.
Higher score is worse outcome.
|
Baseline
|
|
KINAP score
Periodo de tiempo: Baseline
|
The KINAP consists of presenting participants with photographs illustrating physical and sports activities.
For each photograph, participants are asked to rate, on a scale from 0% to 100%, the intensity of their fear regarding potential negative consequences (e.g., pain).
The total score is calculated as the mean of the ratings provided for all photographs and ranges from 0% to 100%.
Higher scores indicate greater fear and represent a worse outcome.
|
Baseline
|
|
Pain catastrophizing scale
Periodo de tiempo: Baseline
|
The Pain Catastrophizing Scale is used to assess the tendency to exaggerate the threat of pain, ruminate about pain, and experience feelings of helplessness in relation to pain.
It consists of 13 items, each rated from 0 ("not at all") to 4 ("all the time").
The total score is calculated as the sum of the scores of the 13 items and ranges from 0 to 52 Higher score is worse outcome.
|
Baseline
|
|
Change in pain score
Periodo de tiempo: Baseline and Day 40
|
Pain score will be measured using visual analogic scale.
Score goes from 0 cm to 10 cm.
Higher score is worse outcome.
|
Baseline and Day 40
|
Colaboradores e Investigadores
Patrocinador
Fechas de registro del estudio
Fechas importantes del estudio
Inicio del estudio (Estimado)
Finalización primaria (Estimado)
Finalización del estudio (Estimado)
Fechas de registro del estudio
Enviado por primera vez
Primero enviado que cumplió con los criterios de control de calidad
Publicado por primera vez (Actual)
Actualizaciones de registros de estudio
Última actualización publicada (Actual)
Última actualización enviada que cumplió con los criterios de control de calidad
Última verificación
Más información
Términos relacionados con este estudio
Términos MeSH relevantes adicionales
Otros números de identificación del estudio
- 29BRC24.0293 - BASICS
Información sobre medicamentos y dispositivos, documentos del estudio
Estudia un producto farmacéutico regulado por la FDA de EE. UU.
Estudia un producto de dispositivo regulado por la FDA de EE. UU.
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .